Specialty hub

Respiratory

Containing dedicated Learning Zones, guidelines, trials and news for related conditions in Respiratory.

Last updated: 9th Mar 2023

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Respiratory is a branch of medicine that specialises in the treatment of diseases that affect the respiratory system, it is also referred to as pulmonology.

Spotlight on infectious diseases at ECCMID 2022

Follow all the latest developments with daily highlights from the 32nd European Congress of Clinical Microbiology and Infectious Diseases in Lisbon, Portugal, 23–26 April 2022.

Learn more

Type 2 Inflammation in Upper and Lower Airway Diseases

A 360º view of type 2 inflammatory diseases

From signalling pathways to practical implications for patients – join six leading experts on type 2 inflammation for over an hour of short video presentations on various related diseases. In managing patients with asthma, chronic rhinosinusitis with nasal polyposis, atopic dermatitis or eosinophilic esophagitis, the scientific background and clinically-focused discussions are not to be missed.

Watch now

Respiratory Syncytial Virus (RSV) in Adults Learning Zone

In this RSV Learning Zone, find out more on risk factors for severe RSV infection, RSV burden, RSV diagnosis, as well as current and future RSV prevention and treatment strategies.

Learn more

Learning Zones

Learning Zone Homepage

Respiratory Syncytial Virus (RSV) in Adults

180 mins

Learning Zone Homepage

Respiratory Care

530 mins

Learning Zone Homepage

Idiopathic Pulmonary Fibrosis

140 mins

Respiratory deals with all aspects of the breathing system as well as being involved with intensive care medicine providing life support and mechanical ventilation. This medical speciality deals with asthma, chronic obstructive pulmonary disease, cystic fibrosis, allergic rhinitis and involved with smoking cessation and sleep apnoea.

It can also cover solid organ transplantation where replacement of the lung is needed for end-stage pulmonary disease from multiple causes.

Diseases in this section

Allergic Rhinitis

Containing relevant Learning Zones, guidelines, trials and news.

Asthma

Containing relevant Learning Zones, guidelines, trials and news.

Chronic Obstructive Pulmonary Disease (COPD)

Containing relevant Learning Zones, guidelines, trials and news.

Cystic Fibrosis

Containing relevant Learning Zones, guidelines, trials and news.

Idiopathic pulmonary fibrosis (IPF)

Containing relevant Learning Zones, guidelines, trials and news.

Nasal polyposis

Containing relevant Learning Zones, guidelines, trials and news.

Respiratory Syncytial Virus (RSV)

Containing relevant Learning Zones, guidelines, trials and news.

Sleep Apnea

Containing relevant Learning Zones, guidelines, trials and news.

Smoking Cessation

Containing relevant Learning Zones, guidelines, trials and news.

Solid Organ Transplantation

Containing relevant Learning Zones, guidelines, trials and news.

Related news and insights

Drug news

FDA AMDAC votes to support Paxlovid for use in COVID-19.- Pfizer

Pfizer announced that the FDA Antimicrobial Drugs Advisory Committee (AMDAC) voted 16 to 1 that available data support the safety and effectiveness of Paxlovid (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adult patients who are at high risk for progression to severe illness.

1 mins

Drug news

New data shows favorable profile of bemnifosbuvir for treatment of COVID-19 and hepatitis C, presented at 2023 International Conference on Antiviral Research.- Atea Pharma

Atea Pharmaceuticals, Inc. has announced the presentation of new Phase 1, in vitro and in vivo data that demonstrate key profile attributes of Atea’s lead drug candidate, bemnifosbuvir, for the treatment of COVID-19 and hepatitis C (HCV). Additionally, new data for AT-752 for dengue and a nucleotide analogue are being presented. These results are being presented at the 36th International Conference on Antiviral Research (ICAR 2023) taking place March 13-17, 2023 in Lyon, France.

1 min

Drug news

Data from a clinical study shows Bentrio nasal spray's residence time and rheological properties superior to saline control.-Altamira Therapetics

Altamira Therapeutics Ltd.reported that data from a recent peer-reviewed clinical study involving Bentrio nasal spray's residence time and other rheological properties demonstrated superiority vs. a saline control.

1 min

See all news

Related Drugs

FDA Hero Banner - Multi-coloured pills and tablets

Benzonatate BENZONATATE 100 mg/1 A-S Medication Solutions

1 mins

Fluticasone Propionate and Salmeterol DISKUS FLUTICASONE PROPIONATE 100 ug/1 A-S Medication Solutions

2 mins

Butalbital, Aspirin, Caffeine and Codeine Phosphate ASPIRIN 325 mg/1 Amneal Pharmaceuticals NY LLC

1 mins

ALBUTEROL SULFATE ALBUTEROL SULFATE 2 mg/5mL QUAGEN PHARMACEUTICALS LLC

1 mins

Benzonatate BENZONATATE 100 mg/1 A-S Medication Solutions

1 mins

Butalbital, Acetaminophen and Caffeine ACETAMINOPHEN 325 mg/1 Par Pharmaceutical, Inc.

1 mins

Benzonatate BENZONATATE 100 mg/1 A-S Medication Solutions

1 mins

Benzonatate BENZONATATE 200 mg/1 NuCare Pharmaceuticals,Inc.

1 mins

Zafirlukast ZAFIRLUKAST 10 mg/1 Bryant Ranch Prepack

1 mins

Butalbital, Acetaminophen, and Caffeine ACETAMINOPHEN 325 mg/1 Cardinal Health 107, LLC

1 mins

Levalbuterol LEVALBUTEROL HYDROCHLORIDE .31 mg/3mL Amneal Pharmaceuticals of New York LLC

1 mins

MONTELUKAST SODIUM MONTELUKAST SODIUM 10 mg/1 Direct_Rx

3 mins

Bromfed DM BROMPHENIRAMINE MALEATE 2 mg/5mL Vertical Pharmaceuticals, LLC

1 mins

Albuterol Sulfate HFA ALBUTEROL SULFATE 90 ug/1 Teva Pharmaceuticals USA, Inc.

2 mins

Theophylline THEOPHYLLINE 300 mg/1 Teva Pharmaceuticals, Inc.

6 mins

Related Journals

Journal

Neutrophils in respiratory syncytial virus infection: From harmful effects to therapeutic opportunities

1 mins

Journal

TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling

1 mins

Journal

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

3 mins

Journal

Risk factors for RSV associated acute lower respiratory infection poor outcome and mortality in young children: A systematic review and meta-analysis

1 mins

Journal

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

1 mins

Journal

Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe

1 mins

Journal

Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets

1 mins

Journal

Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination

1 mins

Journal

Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review

1 mins

Journal

Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections

1 mins

Related Guidelines

Guideline

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

The goal of this guideline is to provide an evidence-based approach to the diagnosis, management, and prevention of bronchiolitis in children from 1 month through 23 months of age.

1 mins

Guideline

Respiratory syncytial virus (RSV): symptoms, transmission, prevention, treatment

Respiratory syncytial virus (RSV) is an enveloped RNA virus, in the same family as the human parainfluenza viruses and mumps and measles viruses

1 min

Guideline

Respiratory syncytial virus (RSV) in preterm and ill infants

Respiratory Syncytial Virus is a virus that causes infections of the lungs and airways. It commonly appears during the coldest and wettest months of the year, similarly to the influenza virus. In adults and older children the symptoms are commonly mild, with cold-like symptoms such as rhinitis or coughing.

1 min

See all guidelines